ESR1 and breast cancer: Novel sulfur-containing ERα modulators (compounds 4 and 5) as potential breast cancer therapeutic drug candidates were designed and synthesized based upon the hydrophobic feedback approach for the simple bisphenols 1–3 developed in our previous studies.